RxDoctor Payments Data

Jane Berger

Family · Sacramento, CANPI 1285906883

Payments from drug & device makers

$4,485in general payments, 2019–2025

Across 244 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$637
  • Lilly USA, LLC$569
  • AbbVie$398
  • Boehringer Ingelheim$327
  • GSK$209
  • Pfizer$200
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$4,485100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,485 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin139$117,985
OzempicSemaglutide63$72,978
TradjentaLinagliptin53$49,644
TrulicityDulaglutide30$33,327
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog59$23,477
JanuviaSitagliptin Phosphate20$18,851
EliquisApixaban23$18,170
Breo ElliptaFluticasone/Vilanterol21$11,124
VascepaIcosapent Ethyl36$8,102
Janumet XrSitagliptin Phos/Metformin Hcl13$7,199
Combivent RespimatIpratropium/Albuterol Sulfate11$5,241
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$4,636
Icosapent Ethyl22$4,446
Atorvastatin Calcium468$3,289
Nano 2nd Gen Pen NeedlePen Needle, Diabetic53$2,802

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$327$172,869203 claims
Novo NordiskOzempic$637$72,97863 claims
Lilly USA, LLCTrulicity$569$33,32730 claims
MerckJanuvia, Janumet Xr$123$26,05033 claims
PfizerEliquis$200$18,17023 claims
GSKBreo Ellipta$209$11,12421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.

Other family in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →